bimagrumab semaglutide combination trial nct ADA 2025: Combination of Bimagrumab and Semaglutide Shows Enhanced Fat Loss and Muscle Preservation

Bimagrumab plus semaglutide alone or in combination for the treatment of obesity: a randomized phase 2 trial

24.90

★★★★☆4.8 (126)

Combination bimagrumab plus semaglutide confers weight loss while preserving lean mass

26.11

★★★★★4.9 (98)

Concentration–time profile of bimagrumab in healthy older adults and

29.00

★★★★★5.0 (157)

A phase 2 clinical trial has demonstrated that bimagrumab, when combined with semaglutide, resulted in significant weight loss for trial participants while maintaining lean muscle mass – suggesting a promising approach for

29.10

★★★★★4.7 (84)

A phase 2 clinical trial has demonstrated that bimagrumab, when combined with semaglutide, resulted in significant weight loss for trial participants while maintaining lean muscle mass – suggesting a promising approach for

28.89

★★★★★4.9 (203)

A phase 2 clinical trial has demonstrated that bimagrumab, when combined with semaglutide, resulted in significant weight loss for trial participants while maintaining lean muscle mass – suggesting a promising approach for

26.19

★★★★★5.0 (176)

New phase 2 data just published in Nature Medicine on bimagrumab combined with semaglutide. Swipe for the breakdown. Follow @adam_nessim for more. Source: Heymsfield et al., Nature Medicine, March 2, 2026

23.94

★★★★★4.8 (132)